Verification of the Quantitative Accuracy of the PET/CT System Imaging Chain
Status: | Not yet recruiting |
---|---|
Healthy: | No |
Age Range: | 40 - Any |
Updated: | 4/2/2016 |
Start Date: | November 2012 |
ROMAN (PCA-9000A) PET/CT System Verification
The purpose of this study will evaluate new technologies that have been included in the new
PCA-9000A PET/CT System.
PCA-9000A PET/CT System.
Scope:
To evaluate the new technologies that have been included in the PCA-9000A PET/CT System, the
study has the following 3 goals.
- Define and confirm all supported clinical protocols from Low-Dose CT, to PET
acquisition and presentation.
- Verification of the quantitative accuracy of the imaging chain.
- Evaluate the performance and stability of the new system and its related quality
control and calibration procedures.
Result (Expected):
The study is an essential step in assessing the quality of the hardware and software
defining the new PCA-9000A PET/CT System. Several essential parameters for the acquisition,
reconstruction, correction, filtering, and presentation will be estimated or adjusted during
this period. The evaluation will confirm PCA-9000A PET/CT System is effective for its
intended use.
To evaluate the new technologies that have been included in the PCA-9000A PET/CT System, the
study has the following 3 goals.
- Define and confirm all supported clinical protocols from Low-Dose CT, to PET
acquisition and presentation.
- Verification of the quantitative accuracy of the imaging chain.
- Evaluate the performance and stability of the new system and its related quality
control and calibration procedures.
Result (Expected):
The study is an essential step in assessing the quality of the hardware and software
defining the new PCA-9000A PET/CT System. Several essential parameters for the acquisition,
reconstruction, correction, filtering, and presentation will be estimated or adjusted during
this period. The evaluation will confirm PCA-9000A PET/CT System is effective for its
intended use.
Inclusion:
- Patients already scheduled for an FDG test at SDMI
- 40 years and older
- Adult must be able to sign an informed consent form
Exclusion
- Patients not scheduled for an FDG test at SDMI
- 39 years or younger
- Pregnant adult female or plan to be pregnant
- Adult who is unable to sign the informed consent
We found this trial at
1
site
Click here to add this to my saved trials